United States · 
Who invested in Aviceda Therapeutics?
Aviceda Therapeutics's investors include OrbiMed, TCG, Catalio Capital Management, TCG Crossover and Blue Owl.
United States · Series C startup
Who invested in Aviceda Therapeutics
Funding summaryUpdated 26 Oct 2026
$208Mraised across 1 round since 2025, from 1 source
- Latest round
- Series C, $208MJan 2025
- Investors
- 5
The rounds
- Jan 2025Series C$208M
Source recordedSEC filing: $75M sold, first sale Dec 2024
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Aviceda Therapeutics
How much has Aviceda Therapeutics raised?
Aviceda Therapeutics has raised $208M across 1 round since 2025.
When did Aviceda Therapeutics last raise?
Aviceda Therapeutics's most recent round was a Series C of $208M in Jan 2025.
What was Aviceda Therapeutics's biggest round?
Its most recent round, $208M in Jan 2025, is also its largest on record.
Who backed Aviceda Therapeutics first?
Aviceda Therapeutics's first round on record, in Jan 2025, was backed by OrbiMed, TCG and Catalio Capital Management and 2 others.
What stage is Aviceda Therapeutics at?
Aviceda Therapeutics's latest named round is a Series C, in Jan 2025.
Where is Aviceda Therapeutics based?
Aviceda Therapeutics is based in the United States.
Companies like Aviceda Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.